Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Prostate Disorders
Trial Information
A 4-Week Phase IIIb Clinical Trial to Evaluate Several Dosage Strengths of the Study Drug in the Treatment of Chronic Prostatitis
Qualified patients will be randomized to one of three treatment
regimens of the study drug. There is no placebo arm to this study.
Patients will be asked to complete up to a 4 week course of oral
medication. There will be 4 study visits and 3 follow up phone
calls at 6 weeks, 12 weeks, and 24 weeks.
Patient Inclusion Criteria
- Males age 40 or older
- Clinical diagnosis and history of chronic prostatitus
Patient Exclusion Criteria
- Prostate carcinoma
- Need for parenteral therapy for prostatitis.
Southeastern Research Group, Inc.
2000 Centre Pointe Boulevard
Tallahassee, FL 32308
Phone: 850-201-0411
EMail: aherberger@serginc.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
